vs
Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and TaoWeave, Inc. (TWAV). Click either name above to swap in a different company.
Lucid Diagnostics Inc. is the larger business by last-quarter revenue ($1.2M vs $622.0K, roughly 1.9× TaoWeave, Inc.). TaoWeave, Inc. runs the higher net margin — -448.2% vs -858.5%, a 410.3% gap on every dollar of revenue. On growth, TaoWeave, Inc. posted the faster year-over-year revenue change (10.5% vs 3.3%). Over the past eight quarters, Lucid Diagnostics Inc.'s revenue compounded faster (7.9% CAGR vs -0.3%).
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
LUCD vs TWAV — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $622.0K |
| Net Profit | $-10.4M | $-2.8M |
| Gross Margin | — | 47.1% |
| Operating Margin | -971.0% | -126.4% |
| Net Margin | -858.5% | -448.2% |
| Revenue YoY | 3.3% | 10.5% |
| Net Profit YoY | 16.0% | -215.4% |
| EPS (diluted) | $-0.10 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $622.0K | ||
| Q3 25 | $1.2M | $601.0K | ||
| Q2 25 | $1.2M | $592.0K | ||
| Q1 25 | $828.0K | $622.0K | ||
| Q4 24 | $1.2M | $563.0K | ||
| Q3 24 | $1.2M | $578.0K | ||
| Q2 24 | $976.0K | $611.0K | ||
| Q1 24 | $1.0M | $626.0K |
| Q4 25 | — | $-2.8M | ||
| Q3 25 | $-10.4M | $-2.3M | ||
| Q2 25 | $-4.4M | $-605.0K | ||
| Q1 25 | $-26.9M | $-672.0K | ||
| Q4 24 | $-11.5M | $-884.0K | ||
| Q3 24 | $-12.4M | $-1.0M | ||
| Q2 24 | $-11.0M | $-983.0K | ||
| Q1 24 | $-10.6M | $-1.1M |
| Q4 25 | — | 47.1% | ||
| Q3 25 | — | 40.6% | ||
| Q2 25 | — | 38.5% | ||
| Q1 25 | — | 40.0% | ||
| Q4 24 | — | 24.0% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 19.6% | ||
| Q1 24 | — | -0.5% |
| Q4 25 | — | -126.4% | ||
| Q3 25 | -971.0% | -133.4% | ||
| Q2 25 | -978.8% | -115.4% | ||
| Q1 25 | -1508.1% | -111.1% | ||
| Q4 24 | -1033.8% | -164.8% | ||
| Q3 24 | -997.8% | -185.5% | ||
| Q2 24 | -1146.7% | -166.6% | ||
| Q1 24 | -1078.1% | -189.1% |
| Q4 25 | — | -448.2% | ||
| Q3 25 | -858.5% | -381.0% | ||
| Q2 25 | -381.7% | -102.2% | ||
| Q1 25 | -3249.8% | -108.0% | ||
| Q4 24 | -964.2% | -157.0% | ||
| Q3 24 | -1055.5% | -179.9% | ||
| Q2 24 | -1127.6% | -160.9% | ||
| Q1 24 | -1060.1% | -181.5% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.52 | — | ||
| Q4 24 | $-0.17 | — | ||
| Q3 24 | $-0.25 | — | ||
| Q2 24 | $-0.23 | — | ||
| Q1 24 | $-0.40 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $2.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $25.8M | $7.0M |
| Total Assets | $53.2M | $8.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.3M | ||
| Q3 25 | $47.3M | $3.7M | ||
| Q2 25 | $31.1M | $10.8M | ||
| Q1 25 | $25.2M | $4.3M | ||
| Q4 24 | $22.4M | $5.0M | ||
| Q3 24 | $14.5M | $5.6M | ||
| Q2 24 | $24.9M | $5.9M | ||
| Q1 24 | $24.8M | — |
| Q4 25 | — | $7.0M | ||
| Q3 25 | $25.8M | $9.8M | ||
| Q2 25 | $7.9M | $11.3M | ||
| Q1 25 | $-5.4M | $3.4M | ||
| Q4 24 | $5.4M | $4.0M | ||
| Q3 24 | $6.3M | $4.7M | ||
| Q2 24 | $16.0M | $5.1M | ||
| Q1 24 | $11.9M | $4.4M |
| Q4 25 | — | $8.2M | ||
| Q3 25 | $53.2M | $10.9M | ||
| Q2 25 | $38.7M | $13.1M | ||
| Q1 25 | $32.8M | $4.8M | ||
| Q4 24 | $30.7M | $5.3M | ||
| Q3 24 | $22.6M | $6.0M | ||
| Q2 24 | $34.1M | $6.3M | ||
| Q1 24 | $32.0M | $5.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.9M | $-744.0K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-744.0K | ||
| Q3 25 | $-10.9M | $-1.6M | ||
| Q2 25 | $-10.5M | $-37.0K | ||
| Q1 25 | $-12.5M | $-680.0K | ||
| Q4 24 | $-9.9M | $-255.0K | ||
| Q3 24 | $-10.2M | $-911.0K | ||
| Q2 24 | $-11.5M | $-1.6M | ||
| Q1 24 | $-12.6M | $-630.0K |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
